Carnitine depletion during total parenteral nutrition despite oral L-carnitine supplementation

Pediatrics International

Volumn 39, Issue 2, 1997, Pages 194-200

  Hirose, Shinichi ^a   Hirata, Masaaki ^a   Azuma, Naomi ^a   Shirai, Zentaro ^a   Mitudome, Akihisa ^a   Oda, Teiichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Carnitine; Short bowel syndrome; Total parenteral nutrition

Indexed keywords

CARNITINE; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ACIDEMIA; ARTICLE; CASE REPORT; CHILD; CHILD GROWTH; CYTOSOL; DIET SUPPLEMENTATION; FATTY ACID OXIDATION; HUMAN; INTESTINE ABSORPTION; LIPID METABOLISM; MALABSORPTION; MALE; MITOCHONDRIAL MEMBRANE; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; SHORT BOWEL SYNDROME; TOTAL PARENTERAL NUTRITION;

ADMINISTRATION, ORAL; CARNITINE; CHILD, PRESCHOOL; HUMANS; INTESTINAL ABSORPTION; MALE; PARENTERAL NUTRITION, TOTAL; SHORT BOWEL SYNDROME;

EID: 0031002471     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03580.x     Document Type: Article

References (37)

1. Bremer J. Carnitine metabolism and functions. Physiol. Rev. 1983; 63: 1420–80.
2. Bieber LL. Carnitine. Annu. Rev. Biochem. 1988; 57: 261–83.
3. Kuratsune H., Yamaguti K., Takahashi M., Misaki H., Tagawa S., Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin. Infect. Dis. 1994; 18: Suppl. 11: S62–7.
4. Stanley CA, DeLeeuw S., Coates PM et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann. Neurol. 1991; 30: 709–16.
5. Steenhout P., Elmer C., Clercx A. et al. Carnitine deficiency with cardiomyopathy presenting as neonatal hydrops: Successful response to carnitine therapy. J. Inherit. Metab. Dis. 1990; 13: 69–75.
6. Bautista J., Rafel E., Martinez A. et al. Familial hypertrophic cardiomyopathy and muscle carnitine deficiency. Muscle Nerve 1990; 13: 192–4.
7. Leatherbury L., Chandra RS, Shapiro SR, Perry LW. Value of endomyocardial biopsy in infants, children and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis. J. Am. Coll. Cardiol. 1988; 12: 1547–54.
8. Scholte HR, Luyt-Houwen IE, Vaandrager-Verduin MH. The role of the carnitine system in myocardial fatty acid oxidation: Carnitine deficiency, failing mitochondria and cardiomyopathy. Basic Res. Cardiol. 1987; 1: 63–73.
9. Colin AA, Jaffe M., Shapira Y., Ne'eman Z., Gutman A., Korman S. Muscle carnitine deficiency presenting as familial fatal cardiomyopathy. Arch. Dis. Child. 1987; 62: 1170–2.
10. Tripp ME, Shug AL. Plasma carnitine concentrations in cardiomyopathy patients. Biochem. Med. 1984; 32: 199–206.
11. Waber LJ, Valle D., Neill C., DiMauro S., Shug A. Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport. J. Pediatr. 1982; 101: 700–5.
12. Siami G., Clinton ME, Mrak R., Griffis J., Stone W. Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis. Nephron 1991; 57: 306–13.
13. Glasgow AM, Eng G., Engel AG. Systemic carnitine deficiency simulating recurrent Reye syndrome. J. Pediatr. 1980; 96: 889–91.
14. Matsuda I. and Ohtani Y. Carnitine status in Reye and Reye-like syndromes. Pediatr. Neurol. 1986; 2: 90–4.
15. Kendler BS. Carnitine: An overview of its role in preventive medicine. Prev. Med. 1986; 15: 373–90.
16. Broquist HP. Carnitine biosynthesis and function. Introductory remarks. Fed. Proc./Fed. Soc. Am. Exp. Biology 1982; 41: 2840–2.
17. Tanphaichitr V., Broquist HP. Role of lysine and N-trimethyllysine in carnitine biosynthesis: II. Studies in the rat. J. Biol. Chem. 1973; 248: 2176–81.
18. Feller AG, Rudman D. Role of carnitine in human nutrition. J. Nutr. 1988; 118: 541–7.
19. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 1988; 319: 1331–6.
20. Tibboel D., Delemarre FM, Przyrembel H., Bos AP, Affourtit MJ, Molenaar JC. Carnitine deficiency in surgical neonates receiving total parenteral nutrition. J. Pediatr. Surg. 1990; 25: 418–21.
21. Worthley LI, Fishlock RC, Snoswell AM. Carnitine deficiency with hyperbilirubinemia, generalized skeletal muscle weakness and reactive hypoglycemia in a patient on long-term total parenteral nutrition: Treatment with intravenous L-carnitine. JPEN. J. Parenter. Enteral. Nutr. 1983; 7: 176–80.
22. Palombo JD, Schnure F., Bistrian BR, Buchanan LM, Blackburn GL. Improvement of liver function tests by administration of L-carnitine to a carnitine-deficient patient receiving home parenteral nutrition: A case report. JPEN. J. Parenter. Enteral. Nutr. 1987; 11: 88–92.
23. Silverman A., Roy CC. Selected laboratory tests. In: Pediatric Clinical Gastroenterology. Mosby, St Louis. 1983; 889–90.
24. Takahashi M. Ueda S. Misaki H. et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin. Chem. 1994; 40: 817–21.
25. Rizza V., Lorefice R., Rizza N., Calabrese V. Pharmacokinetics of L-carnitine in human subject. In: Ferrari R., DiMauro S. (eds). L-Carnitine and Its Role In Medicine: From Function to Therapy. Academic Press, London. 1992; 63–77.
26. Gross CJ, Henderson LM. Absorption of D- and L-carnitine by the intestine and kidney tubule in the rat. Biochim. Biophys. Acta. 1984; 772: 209–19.
27. Shaw RD, Li BU, Hamilton JW, Shug AL, Olsen WA. Carnitine transport in rat small intestine. Am. J. Physiol. 1983; 245: 376–81.
28. Rebouche CJ. Carnitine transport and tissue carnitine accretion in rats. Biochim. Biophys. Acta. 1990; 1033: 111–13.
29. Melegh B. Carnitine supplementation in the premature. Biol. Neonate. 1990; 1: 93–106.
30. Rebouche CJ, Engel AG. Tissue distribution of carnitine biosynthetic enzymes in man. Biochim. Biophys. Acta. 1980; 630: 22–9.
31. Moukarzel AA, Dahlstrom KA, Buchman AL, Ament ME. Carnitine status of children receiving long-term total parenteral nutrition: A longitudinal prospective study. J. Pediatr. 1992; 120: 759–62.
32. Dahlstrom KA, Ament ME, Moukarzel A., Vinton NE, Cederblad G. Low blood and plasma carnitine levels in children receiving long-term parenteral nutrition. J. Pediatr. Gastroenterol. Nutr. 1990; 11: 375–9.
33. Orzali A., Donzelli F., Enzi G., Rubaltelli FF. Effect of carnitine on lipid metabolism in the newborn: I. Carnitine supplementation during total parenteral nutrition in the first 48 hours of life. Biol. Neonate 1983; 43: 186–90.
34. Schmidt-Sommerfeld E., Penn D., Wolf H. Carnitine blood concentrations and fat utilization in parenterally alimented premature newborn infants. J. Pediatr. 1982; 100: 260–4.
35. Helms RA, Mauer EC, Hay W. Jr, Christensen ML, Storm MC. Effect of intravenous L-carnitine on growth parameters and fat metabolism during parenteral nutrition in neonates. JPEN. J. Parenter. Enteral. Nutr. 1990; 14: 448–53.
36. Helms RA, Whitington PF, Mauer EC, Catarau EM, Christensen ML, Borum PR. Enhanced lipid utilization in infants receiving oral L-carnitine during long-term parenteral nutrition. J. Pediatr. 1986; 109: 984–8.
37. Bonner CM, DeBrie KL, Hug G., Landrigan E., Taylor BJ. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J. Pediatr. 1995; 126: 287–92.